Articles include:

• Dear Reader
• Board of Directors: Myeloma Today in conversation with Edith Peterson Mitchell, MD, FACP
• Scientific & Clinical: The Role of Zolinza® in Multiple Myeloma; Myeloma Today in conversation with Dr. David Siegel
• Scientific & Clinical: Phase III Zolinza®/Velcade® Trial Opening Soon; Myeloma Today in conversation with Dr. Sundar Jagannath
• Scientific & Clinical: Serum Immunoglobulin Free Light Chain Assay in Myeloma; Myeloma Today in conversation with Dr. Angela Dispenzieri
• Nurse Leadership Board: NLB Activities Update; Myeloma Today in conversation with Elizabeth Bilotti and Beth Faiman
• Supportive Care: Steroid-Associated Side Effects in Patients with Myeloma; Myeloma Today in conversation with Patricia A. Mangan, MSN, AOCN, CRNP
• Supportive Care: IMF Hotline Coordinators Answer Your Questions: "My father was just diagnosed with what the doctor says is early stage asymptomatic multiple myeloma. The doctor doesn’t want to start treatment yet and just wants to follow him. I thought that once you were diagnosed with cancer, the best thing was to treat it as quickly as possible. Why would they just follow my father’s myeloma and not get started with treatment since they found it early?"
• Education and Awareness: Spotlight on Advocacy; Congress Focuses on Cancer Related Legislation by Christine Murphy, MA
• Support Group Profiles:
  • Connecticut Support Group Stands Up To Cancer
  • The North Florida Multiple Myeloma Support Group
  • New Support Group is formed in Louisiana
• International Affiliates: Updates from Around the Globe
  • Dr. Robert A. Kyle Meets with European Patients and Doctors
  • Expanded Approval of VELCADE® for Previously Untreated Patients
• Patient and Caregiver Experience: Coping with Fear and Cancer Recurrence by John M. Ricco
• Member Events: IMFers Raise Funds to Benefit Myeloma Community
  • A Wedding Celebration to Remember
  • Young Artist Chooses the IMF as Honored Charity
  • Young Yard Sale
  • Turn Your Vacations Into Donations
  • Planned Giving
• Investing in the Future: Myeloma Today in conversation with Leslie Byrnes
• Cell Phones For A Cure
• News & Notes
• 2008 IMF Calendar of Events
• Letters to the IMF